Detalles de la búsqueda
1.
Efficacy and safety of immune checkpoint inhibitors combined with recombinant human endostatin and chemotherapy as the first-line treatment of advanced non-small-cell lung cancer.
Future Oncol
; 19(2): 147-158, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779488
2.
Immunotherapy combined with rh-endostatin improved clinical outcomes over immunotherapy plus chemotherapy for second-line treatment of advanced NSCLC.
Front Oncol
; 13: 1137224, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37035161
3.
BMI1 induces ubiquitination and protein degradation of Nod-like receptor family CARD domain containing 5 and suppresses human leukocyte antigen class I expression to induce immune escape in non-small cell lung cancer.
Kaohsiung J Med Sci
; 38(12): 1190-1202, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36194200
Resultados
1 -
3
de 3
1
Próxima >
>>